Ex Parte COOKE et al - Page 3




          Appeal No. 2003-1918                                                        
          Application No. 08/945,722                                                  

               Rather than reiterate the respective positions advocated by            
          the appellants and by the examiner concerning these rejections,             
          we refer to the brief and reply brief and to the answer for a               
          complete exposition thereof.                                                
                                       OPINION                                        
               For the reasons which follow, we will sustain each of the              
          above noted rejections.                                                     
               With respect to each of the rejections before us, the                  
          appellants implicitly concede that the “Superlose”-based starch             
          of Elizer contains the amylose content required by the appealed             
          independent claims but argue that “such starch would not fall               
          within the present invention as it is not a starch ‘comprising              
          granules extracted from a potato plant’” (brief, page 6).                   
               This argument is unpersuasive with respect to independent              
          claim 64 since this claim is not limited to “a starch ‘comprising           
          granules extracted from a potato plant’” (id.).  See In re Self,            
          671 F.2d 1344, 1348-49, 213 USPQ 1, 5 (CCPA 1982).                          
               Although independent claim 1 contains the limitation in                
          question, the appellants’ argument also is unpersuasive with                
          respect to this claim.  Concerning this limitation, the                     


          claims will stand or fall with independent claims 1 and 64.                 

                                          3                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007